{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:06:35Z","timestamp":1785409595357,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.amjopharm.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T11:10:45Z","timestamp":1354619445000},"page":"381-389.e3","source":"Crossref","is-referenced-by-count":12,"title":["Atypical Antipsychotic Use and Parkinsonism in Dementia: Effects of Drug, Dose, and Sex"],"prefix":"10.1016","volume":"10","author":[{"given":"Connie","family":"Marras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas D.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Rochon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2012.11.001_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF03324754","article-title":"Men: good health and high mortality. Sex differences in health and aging","volume":"20","author":"Oksuzyan","year":"2008","journal-title":"Aging-Clin Exp Res"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archinte.158.5.449","article-title":"Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization","volume":"158","author":"Barron","year":"1998","journal-title":"Arch Int Med"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib3","series-title":"State Operations Manual","year":"2011"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/archinte.165.16.1882","article-title":"Atypical antipsychotics and parkinsonism","volume":"165","author":"Rochon","year":"2005","journal-title":"Arch Int Med"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox model with cumulative sums of Martingale residuals","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.wnl.0000215428.46057.3d","article-title":"Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"66","author":"Miyasaki","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/JGP.0b013e3182051bd6","article-title":"Antipsychotics and mortality in parkinsonism","volume":"20","author":"Marras","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib9","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archneurol.2011.139","article-title":"Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis","volume":"68","author":"Weintraub","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/01.wnl.0000260060.60870.89","article-title":"Quetiapine for agitation or psychosis in patients with dementia and parkinsonism","volume":"68","author":"Kurlan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/gps.1892","article-title":"Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study","volume":"23","author":"Paleacu","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.eurpsy.2007.03.001","article-title":"Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function","volume":"22","author":"Rainer","year":"2007","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.JGP.0000196628.12010.35","article-title":"Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial","volume":"14","author":"Tariot","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/156720507779939805","article-title":"Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study","volume":"4","author":"Zhong","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib16","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4088\/JCP.v63n1211","article-title":"Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis","volume":"63","author":"Sajatovic","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib17","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/10673221003747690","article-title":"The elderly safety imperative and antipsychotic usage","volume":"18","author":"Chahine","year":"2010","journal-title":"Harvard Rev Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00019442-200508000-00012","article-title":"Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia","volume":"13","author":"Deberdt","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.22.1.1.33496","article-title":"Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis","volume":"22","author":"Ellingrod","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4088\/JCP.v64n0617","article-title":"A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities","volume":"64","author":"Fontaine","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.archger.2004.04.029","article-title":"Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD)","author":"Gareri","year":"2004","journal-title":"Arch Gerontol Geriatr Suppl"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/appi.ps.62.10.1207","article-title":"After the black box warning: predictors of psychotropic treatment choices for older patients with dementia","volume":"62","author":"Kim","year":"2011","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/00048674.2010.538839","article-title":"Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: findings of the Research on Asia Psychotropic Prescription (REAP) studies","volume":"45","author":"Xiang","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.jcp.0000185423.15891.02","article-title":"Sex differences in the subjective tolerability of antipsychotic drugs","volume":"25","author":"Barbui","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2012.11.001_bib26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594612001298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594612001298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T11:28:13Z","timestamp":1562412493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594612001298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1543594612001298"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2012.11.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}